Moreover, paxillin mutations have been implicated in the poor prognosis of various invasive tumors, including breast [27], [28], lung [29], [30], and melanoma [31], [32], suggesting that paxillin is important for controlling cell migration and invasion in living tissues. This evidence concerns the gene PXN and melanoma.